Reviva Pharma Stock Is Trading Higher After Maxim Initiated With Buy, Target Price Of $10

  • Reviva Pharmaceuticals Holdings Inc RVPH is trading higher with around 60k in session volume.
  • Maxim initiated coverage of Reviva with a Buy rating and $10 price target, equivalent to an upside of around 140%.
  • The company is developing its lead asset, RP5063 (brilaroxazine), to treat schizophrenia and respiratory indications. 
  • Analyst Jason McCarthy tells in a research note that RP5063 features a multimodal mechanism of action, which is "more completely" addressing the mix of positive, negative, and cognitive symptoms associated with schizophrenia.
  • In April, RP5063 showed positive action in the schizophrenia trial that met its primary endpoint of disease severity versus placebo.
  • Price Action: RVPH shares are up 9.92% at $4.21 during the market session on the last check Monday.

Posted In: BriefsBiotechLong IdeasNewsHealth CarePrice TargetInitiationAnalyst RatingsMoversTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.